Frontlight ResearchEarly access
Active, not recruitingPhase 4
Efficacy of Donepezil in Patients With Chronic Tinnitus
Key facts
- Who runs it
- University of Sao Paulo
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- NCT07153991
- U1111-1248-6988
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 70 people, planned
- Started
- 19 Nov 2021
- Ended
- 9 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Donepezil group
- Placebo group
- Record updated
- 4 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- patients with chronic sensorineural tinnitus type
Who cannot take part
- pregnancy, arrhythmia, donepezil allergy, yelow dye allergy, otitis or any ear inflamatory diseases, patients taking any medication for dementia, convulsive diseases, asthma, patients taking any of these medications: carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampicin, ketoconazole, quinidine
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
The 2 groups in the trial
- Intervention Group (donepezil)Treatment being tested
35 Participants with tinnitus received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
Treatment: Donepezil group
- Placebo groupPlacebo, for comparison
35 Pacients with tinnitus received for 3 months placebo medication
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 4 September 2025